Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.42 USD | +17.15% | +39.26% | +126.06% |
05-10 | Transcript : Humacyte, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
03-28 | Transcript : Humacyte, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+126.06% | 765M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+46.73% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- HUMA Stock
- News Humacyte, Inc.
- Humacyte Seeks FDA Approval of Bioengineered Tissue for Treatment of Vascular Injuries